NCT00128635View on ClinicalTrials.gov

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

October 31, 2007

Conditions
Brain and Central Nervous System Tumors
Interventions
RADIATION

iodine I 131 monoclonal antibody TNT-1/B

Trial Locations (4)

30322

Winship Cancer Institute of Emory University, Atlanta

35294

Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham, Birmingham

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT00128635 - Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter